» Articles » PMID: 32487820

Epigenetics of Paraoxonases

Overview
Specialty Biochemistry
Date 2020 Jun 4
PMID 32487820
Citations 9
Authors
Affiliations
Soon will be listed here.
Abstract

Purpose Of Review: Studies have shown the three-member paraoxonase (PON) multigene family to be involved in the development of a large variety of diseases with an inflammatory component. Environmental factors such as lifestyle-related factors differ widely between populations and it is important to consider that their impacts may be exerted through the epigenetic mechanisms, which connect genes, the environment and disease development and are a potential therapeutic avenue.

Recent Findings: In the review period, very little was published on epigenetics of PON2 or PON3, mostly on their diagnostic value in cancer by measuring methylation levels of these genes. However, the picture is more promising with PON1. Here, several studies have linked the epigenetic regulation of PON1 to various metabolic processes and particularly to the development of several diseases, including stroke, heart disease, aortic valve stenosis and chronic obstructive pulmonary disease.

Summary: Studies into the epigenetic regulation of the PON family are in their infancy. However, recent studies linking epigenetic regulation of PON1 to disease development will encourage further research and open up the possibility for new potential therapeutic interventions.

Citing Articles

PON-1 and PON-2 Polymorphisms and PON-1 Paraoxonase Activity in People Living with HIV-1.

Reichert C, Levy D, Maselli L, da Cunha J, Gualandro S, Bydlowski S Antioxidants (Basel). 2025; 14(2).

PMID: 40002395 PMC: 11851513. DOI: 10.3390/antiox14020209.


Exploring the protective role of green tea extract against cardiovascular alterations induced by chronic REM sleep deprivation via modulation of inflammation and oxidative stress.

Coluk Y, Peker E, Yildirmak S, Keskin A, Yildirim G BMC Complement Med Ther. 2024; 24(1):351.

PMID: 39363261 PMC: 11448275. DOI: 10.1186/s12906-024-04643-7.


The Regulatory Variant -108C/T in the Promoter of Paraoxonase 1 (PON1) Gene has a More Important Role in Regulating PON1 Activity Compared to rs3735590 in 3'-UTR in Patients with Coronary Artery Disease.

Zargari M, Maadi N, Rezapour M, Bagheri A, Fallahpour S, Nosrati M Adv Biomed Res. 2024; 13:38.

PMID: 39224397 PMC: 11368222. DOI: 10.4103/abr.abr_391_22.


Altered expression of miR-375 and miR-541 in type 2 diabetes patients with and without coronary artery disease (CAD): the potential of miR-375 as a CAD biomarker.

Sangali P, Abdullahi S, Nosrati M, Khosravi-Asrami O, Mahrooz A, Bagheri A J Diabetes Metab Disord. 2024; 23(1):1101-1106.

PMID: 38932834 PMC: 11196532. DOI: 10.1007/s40200-024-01391-w.


Paraoxonase 1 and atherosclerosis.

Durrington P, Bashir B, Soran H Front Cardiovasc Med. 2023; 10:1065967.

PMID: 36873390 PMC: 9977831. DOI: 10.3389/fcvm.2023.1065967.